Skip to main content
SpringerLink
Log in

Therapeutic Approaches to Subcutaneous Mycoses

American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Subcutaneous mycoses, which are much less common than superficial fungal infections, are characterized by a heterogeneous group of infections that often result from direct penetration of the fungus into the dermis and subcutaneous tissue through traumatic injury. The fungus spreads by local deep tissue invasion from the inoculation site. The disease usually remains localized and then slowly spreads to adjacent tissue and eventually to the lymphatics. More rarely, hematogenous dissemination is observed. There are usually various clinical features and thus a broad range of differential diagnoses. The common subcutaneous mycoses are sporotrichosis, chromoblastomycosis, phaeohyphomycosis, eumycotic mycetoma, and hyalohyphomycosis. Many subcutaneous mycoses are confined to the tropical and subtropical regions, but some, such as sporotrichosis, are also prevalent in temperate regions. Subcutaneous mycoses can occur in healthy individuals. In immunocompromised individuals, these infections can disseminate widely.

Treatment usually involves use of antifungal agents and/or surgical excision. Treatment of some serious subcutaneous mycoses remains unresolved, and there have been reports of relapses or progression during therapy and problems with lack of tolerability of antifungal drugs. Identification of the etiologic agent by culture is essential for prognostic and management considerations, since some fungi are more frequently associated with dissemination. Results of antifungal susceptibility tests may provide valuable information for deciding the appropriate method of treatment. Development of new antifungal agents and combination therapies may result in improvement in the management of subcutaneous mycoses in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price includes VAT (France)

Instant access to the full article PDF.

Institutional subscriptions

Table I

References

  1. Matsumoto T, Matsuda T. Sporotrichosis, chromoblastomycosis, and phaeohyphomycosis: diagnosis and treatment. Dermatol Ther 1997; 3: 91–6

    Google Scholar 

  2. Liu X, Lin X. A case of cutaneous disseminated sporotrichosis. J Dermatol 2001; 28: 95–9

    PubMed  CAS  Google Scholar 

  3. Shaw JC, Levinson W, Montanaro A. Sporotrichosis in the acquired immunodeficiency syndrome. J Am Acad Dermatol 1989; 21: 1145–7

    Article  PubMed  CAS  Google Scholar 

  4. Fitzpatrick JE, Eubanks S. Acquired immunodeficiency syndrome presenting as disseminated cutaneous sporotrichosis. Int J Dermatol 1988; 27: 406–7

    Article  PubMed  CAS  Google Scholar 

  5. Gordhan A, Ramdial PK, Morar N, et al. Disseminated cutaneous sporotrichosis: a marker of osteoarticular sporotrichosis masquerading as gout. Int J Dermatol 2001; 40: 717–9

    Article  PubMed  CAS  Google Scholar 

  6. Kauffman CA, Hajjeh R, Chapman SW. Practice guidelines for the management of patients with sporotrichosis. Clin Infect Dis 2000; 30: 684–7

    Article  PubMed  CAS  Google Scholar 

  7. Sharkey-Mathis PK, Kauffman CA, Graybill JR, et al. Treatment of sporotrichosis with itraconazole. Am J Med 1993; 95: 279–85

    Article  PubMed  CAS  Google Scholar 

  8. Kauffman CA. Old and new therapies for sporotrichosis. Clin Infect Dis 1995; 21: 981–5

    Article  PubMed  CAS  Google Scholar 

  9. Restrepo A, Robledo J, Gomez I, et al. Itraconazole therapy in lymphangitic and cutaneous sporotrichosis. Arch Dermatol 1986; 122: 413–7

    Article  PubMed  CAS  Google Scholar 

  10. Conti Diaz IA, Civila E, Gezuele E, et al. Treatment of human cutaneous sporotrichosis with itraconazole. Mycoses 1992; 35: 153–6

    Article  PubMed  CAS  Google Scholar 

  11. Kauffman CA, Pappas PG, McKinsey DS, et al. Treatment of lymphocutaneous and visceral sporotrichosis with fluconazole. Clin Infect Dis 1996; 22: 46–50

    Article  PubMed  CAS  Google Scholar 

  12. Diaz M, Negroni R, Montero-Gei F, et al. A pan-American 5-year study of fluconazole therapy for deep mycoses in the immunocompetent host. Clin Infect Dis 1992; 14 Suppl. 1: S68–76

    Article  Google Scholar 

  13. Castro LG, Belda Jr W, Cuce LC, et al. Successful treatment of sporotrichosis with oral fluconazole: a report of three cases. Br J Dermatol 1993; 128: 352–6

    Article  PubMed  CAS  Google Scholar 

  14. Habte-Gabr E, Walsh W. Cutaneous sporotrichosis: the old iodide treatment remains effective. Clin Microbiol Infect 2000; 6: 53–5

    Article  PubMed  CAS  Google Scholar 

  15. Lesher Jr JL, Fitch MH, Dunlap DB. Subclinical hypothyroidism during potassium iodide therapy for lymphocutaneous sporotrichosis. Cutis 1994; 53: 128–30

    PubMed  Google Scholar 

  16. Vandervee EE. Sporotrichosis in pregnancy. Cutis 1982; 30: 761–3

    Google Scholar 

  17. Hay RJ. Therapeutic potential of terbinafine in subcutaneous and systemic mycoses. Br J Dermatol 1999; 141 Suppl. 56: 36–40

    Article  PubMed  Google Scholar 

  18. Perez A. Terbinafine: broad new spectrum of indications in several subcutaneous and systemic and parasitic diseases. Mycoses 1999; 42 Suppl. 2: 111–4

    Article  PubMed  CAS  Google Scholar 

  19. Hull PR, Vismer HF. Treatment of cutaneous sporotrichosis with terbinafine. Br J Dermatol 1992; 126 Suppl. 39: 51–5

    Article  PubMed  Google Scholar 

  20. Pappas PG, Bustamante B, Nolasco D, et al Treatment of lymphocutaneous sporotrichosis with terbinafine: results of randomized double-blind trial [abstract 648]. 39th Annual Meeting of the Infectious Diseases Society of America; 2001 Oct 25–28, San Francisco

    Google Scholar 

  21. Hiruma M, Kawada A, Noguchi H, et al. Hyperthermic treatment of sporotrichosis: experimental use of infrared and far infrared rays. Mycoses 1992; 35: 293–9

    Article  PubMed  CAS  Google Scholar 

  22. Matsumoto T. Chromoblastomycosis and phaeohyphomycosis. In: Guerrant RL, Walker DH, Weller PF, et al., editors. Tropical infectious diseases: principles, pathogens, and practice. Philadelphia (PA): Churchill Livingstone, 1999: 621–5

    Google Scholar 

  23. Restrepo A. Treatment of tropical mycoses. J Am Acad Dermatol 1994; 31: S91–102

    Article  Google Scholar 

  24. Minotto R, Bernardi CD, Mallmann LF, et al. Chromoblastomycosis: a review of 100 cases in the state of Rio Grande do Sul, Brazil. J Am Acad Dermatol 2001; 44: 585–92

    Article  PubMed  CAS  Google Scholar 

  25. Dixon DM, Polak-Wyss A. The medically important dematiaceous fungi and their identification. Mycoses 1991; 34: 1–18

    Article  PubMed  CAS  Google Scholar 

  26. Queiroz-Telles F, Purim KS, Fillus JN, et al. Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi. Int J Dermatol 1992; 31: 805–12

    Article  PubMed  CAS  Google Scholar 

  27. Esterre P, Inzan CK, Ramarcel ER, et al. Treatment of chromomycosis with terbinafine: preliminary results of an open pilot study. Br J Dermatol 1996; 134 Suppl. 46: S33–6

    Article  PubMed  Google Scholar 

  28. Tagami H, Ginoza M, Imaizumi S, et al. Successful treatment of chromoblastomycosis with topical heat therapy. J Am Acad Dermatol 1984; 10: 615–9

    Article  PubMed  CAS  Google Scholar 

  29. Matsumoto T, Ajello L, Matsuda T, et al. Developments in hyalohyphomycosis and phaeohyphomycosis. J Med Vet Mycol 1994; 32 Suppl. 1: S329

    Article  PubMed  Google Scholar 

  30. Bittencourt AL, Machado PR, Araujo MG. Subcutaneous phaeohyphomycosis caused by Cyphellophora pluriseptata. Eur J Dermatol 2002; 12: 103–6

    PubMed  Google Scholar 

  31. Matsumoto T. Wangiella dermatitidis infections: a paradigm of the opportunistic mycoses caused by black yeasts and moulds. Korean J Med Mycol 2000; 5: 45–50

    Google Scholar 

  32. Gerdsen R, Uerlich M, De Hoog GS, et al. Sporotrichoid phaeohyphomycosis due to Alternaria infectoria. Br J Dermatol 2001; 145: 484–6

    Article  PubMed  CAS  Google Scholar 

  33. Matsumoto T, Ajello L. Agents of phaeohyphomycosis. In: Collier L, Balows A, Sussman M, editors. Topley & Wilson’s microbiology and microbial infections. 9th ed. Vol. 4. London: Arnold, 1998: 503–24

    Google Scholar 

  34. Xu X, Low DW, Palevsky HI, et al. Subcutaneous phaeohyphomycotic cysts caused by Exophiala jeanselmei in a lung transplant patient. Dermatol Surg 2001; 27: 343–6

    Article  PubMed  CAS  Google Scholar 

  35. Gugnani HC, Sood N, Singh B, et al. Case report: subcutaneous phaeohyphomycosis due to Cladosporium cladosporioides. Mycoses 2000; 43: 85–7

    Article  PubMed  CAS  Google Scholar 

  36. Vieira MR, Milheiro A, Pacheco FA. Phaeohyphomycosis due to Cladosporium cladosporioides. Med Mycol 2001; 39: 135–7

    PubMed  CAS  Google Scholar 

  37. Sharkey PK, Graybill JR, Rinaldi MG, et al. Itraconazole treatment of phaeohyphomycosis. J Am Acad Dermatol 1990; 23: 577–86

    Article  PubMed  CAS  Google Scholar 

  38. Clancy CJ, Wingard JR, Hong Nguyen M. Subcutaneous phaeohyphomycosis in transplant recipients: review of the literature and demonstration of in vitro synergy between antifungal agents. Med Mycol 2000; 38: 169–75

    PubMed  CAS  Google Scholar 

  39. Caligiorne RB, Resende MA, Melillo PH, et al. In vitro susceptibility of chromoblastomycosis and phaeohyphomycosis agents to antifungal drugs. Med Mycol 1999; 37: 405–9

    Article  PubMed  CAS  Google Scholar 

  40. O’Quinn RP, Hoffmann JL, Boyd AS. Colletotrichum species as emerging opportunistic fungal pathogens: a report of 3 cases of phaeohyphomycosis and review. J Am Acad Dermatol 2001; 45: 56–61

    Article  PubMed  Google Scholar 

  41. Poncio Mendes R, Negroni R, Bonifaz A, et al. New aspects of some endemic mycoses. Med Mycol 2000; 38 Suppl. 1: 237–41

    PubMed  Google Scholar 

  42. Bernstein EF, Schuster MG, Stieritz DD, et al. Disseminated cutaneous Pseudallescheria boydii. Br J Dermatol 1995; 132: 456–60

    Article  PubMed  CAS  Google Scholar 

  43. Ginter G, Petutschnig B, Pierer G, et al. Atypical cutaneous pseudallescheriosis refractory to antifungal agents. Mycoses 1999; 42: 507–11

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from the Ministry of Education, Science, Sports and culture of Japan, and also from the Ministry of Health and Welfare of Japan.

Author information

Authors and Affiliations

  1. Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Maidashi, Higashi-ku, 3-1-1, J-812-8582, Fukuoka, Japan

    Tetsuya Koga, Tetsuo Matsuda & Masutaka Furue

  2. Department of Dermatology, Toshiba Hospital, Tokyo, Japan

    Tadahiko Matsumoto

Authors
  1. Tetsuya Koga
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tetsuo Matsuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tadahiko Matsumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masutaka Furue
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tetsuya Koga.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koga, T., Matsuda, T., Matsumoto, T. et al. Therapeutic Approaches to Subcutaneous Mycoses. Am J Clin Dermatol 4, 537–543 (2003). https://doi.org/10.2165/00128071-200304080-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128071-200304080-00003

Keywords

search

Navigation